| The evaluation of genomic applications in practice and prevention (EGAPP) initiative: methods of the EGAPP working group SM Teutsch, LA Bradley, GE Palomaki, JE Haddow, M Piper, N Calonge, ... Genetics in medicine 11 (1), 3-14, 2009 | 785 | 2009 |
| Dry spots and wet spots in the Andean hotspot TJ Killeen, M Douglas, T Consiglio, PM Jørgensen, J Mejia Journal of Biogeography 34 (8), 1357-1373, 2007 | 291 | 2007 |
| Genetic test availability and spending: where are we now? Where are we going? KA Phillips, PA Deverka, GW Hooker, MP Douglas Health affairs 37 (5), 710-716, 2018 | 260 | 2018 |
| Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review GE Palomaki, LA Bradley, MP Douglas, K Kolor, WD Dotson Genetics in Medicine 11 (1), 21-34, 2009 | 184 | 2009 |
| DNA damage caused by common cytological fixatives MP Douglas, SO Rogers Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 401 (1 …, 1998 | 158 | 1998 |
| The economic value of personalized medicine tests: what we know and what we need to know KA Phillips, J Ann Sakowski, J Trosman, MP Douglas, SY Liang, ... Genetics in Medicine 16 (3), 251-257, 2014 | 157 | 2014 |
| Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium … MF Schinsky, RE Morey, AG Steigerwalt, MP Douglas, RW Wilson, ... International Journal of Systematic and Evolutionary Microbiology 54 (5 …, 2004 | 124 | 2004 |
| Assignment of CDC Weak Oxidizer Group 2 (WO-2) to the Genus Pandoraea and Characterization of Three NewPandoraea Genomospecies MI Daneshvar, DG Hollis, AG Steigerwalt, AM Whitney, L Spangler, ... Journal of clinical microbiology 39 (5), 1819-1826, 2001 | 91 | 2001 |
| Paracoccus yeeii sp. nov. (Formerly CDC Group EO-2), a Novel Bacterial Species Associated with Human Infection MI Daneshvar, DG Hollis, RS Weyant, AG Steigerwalt, AM Whitney, ... Journal of clinical microbiology 41 (3), 1289-1294, 2003 | 86 | 2003 |
| Genomic sequencing: assessing the health care system, policy, and big-data implications KA Phillips, JR Trosman, RK Kelley, MJ Pletcher, MP Douglas, ... Health affairs 33 (7), 1246-1253, 2014 | 82 | 2014 |
| Availability and funding of clinical genomic sequencing globally KA Phillips, MP Douglas, S Wordsworth, J Buchanan, DA Marshall BMJ global health 6 (2), e004415, 2021 | 72 | 2021 |
| Prioritizing genomic applications for action by level of evidence: a horizon‐scanning method WD Dotson, MP Douglas, K Kolor, AC Stewart, MS Bowen, M Gwinn, ... Clinical Pharmacology & Therapeutics 95 (4), 394-402, 2014 | 72 | 2014 |
| Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of com parative effectiveness research. KA Phillips, PA Deverka, HC Sox, MJ Khoury, LG Sandy, GS Ginsburg, ... Genetics in Medicine 19 (10), 1081-1091, 2017 | 71* | 2017 |
| Enterococcus porcinus sp. nov. and Enterococcus ratti sp. nov., associated with enteric disorders in animals. LM Teixeira, MG Carvalho, MM Espinola, AG Steigerwalt, MP Douglas, ... International journal of systematic and evolutionary microbiology 51 (5 …, 2001 | 69 | 2001 |
| Payer coverage policies for multigene tests KA Phillips, PA Deverka, JR Trosman, MP Douglas, JD Chambers, ... Nature biotechnology 35 (7), 614-617, 2017 | 59 | 2017 |
| Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: Results of a study from the Program in Prenatal and Pediatric Genomic … JR Trosman, CB Weldon, A Slavotinek, ME Norton, MP Douglas, ... Genetics in medicine 22 (2), 283-291, 2020 | 57 | 2020 |
| Payer coverage for hereditary cancer panels: barriers, opportunities, and implications for the precision medicine initiative JR Trosman, CB Weldon, MP Douglas, AW Kurian, RK Kelley, ... Journal of the National Comprehensive Cancer Network 15 (2), 219-228, 2017 | 53 | 2017 |
| Private payer coverage policies for exome sequencing (ES) in pediatric patients: trends over time and analysis of evidence cited MP Douglas, SL Parker, JR Trosman, AM Slavotinek, KA Phillips Genetics in Medicine 21 (1), 152-160, 2019 | 38 | 2019 |
| Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial KD Christensen, JL Vassy, KA Phillips, CL Blout, DR Azzariti, CY Lu, ... Genetics in Medicine 20 (12), 1544-1553, 2018 | 38 | 2018 |
| Expanding use of clinical genome sequencing and the need for more data on implementation KA Phillips, MP Douglas, DA Marshall Jama 324 (20), 2029-2030, 2020 | 37 | 2020 |
